Form 4: REGENXBIO Inc. Executive Patrick J. Christmas Reports Acquisition of Common Stock

Chief Legal Officer Patrick J. Christmas reports acquisition of 56,446 shares of REGENXBIO Inc. common stock through a restricted stock unit award.

Summary

• On August 1, 2024, Patrick J. Christmas, Chief Legal Officer of REGENXBIO Inc., acquired 56,446 shares of common stock.
• The acquisition was through a time-based restricted stock unit (RSU) award.
• The price per share was $0.00.
• Following the transaction, Christmas directly owns 172,205 shares of REGENXBIO Inc.
• 25% of the shares subject to the RSU will vest on February 1, 2025, August 1, 2025, February 1, 2026, and August 1, 2026, contingent upon continuous service to the Issuer.

Sentiment

Score: 6

Explanation: Neutral sentiment. This is a standard disclosure of stock acquisition by an executive. The vesting schedule suggests a long-term commitment.

Positives

• The acquisition of shares by a key executive could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedule of the RSU award indicates a long-term commitment from the executive to the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's confidence in the company.

Stakeholder Impact

• The acquisition of shares by a key executive could positively influence shareholder sentiment.

Key Dates